SCHEDULE 13G
Statement of Beneficial Ownership
Avalo Therapeutics, Inc. Filed Acc 0001104659-25-049515
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · BVF PARTNERS L P/IL 1.7%
- 2026-11-16 SCHEDULE 13G/A · Point72 Asset Management, L.P. 3.0%
- 2026-11-13 SCHEDULE 13G · Farallon Capital Management, L.L.C. 7.4%
- 2026-05-15 SCHEDULE 13G/A · Logos Global Management LP 3.2%
- 2026-04-01 SCHEDULE 13G · Logos Global Management LP 5.6%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…